1.
J Med Chem
; 49(4): 1231-4, 2006 Feb 23.
Artículo
en Inglés
| MEDLINE
| ID: mdl-16480259
RESUMEN
Antagonism of the bradykinin B1 receptor represents a potential treatment for chronic pain and inflammation. Novel antagonists were designed that display low-nanomolar affinity for the human bradykinin B1 receptor and good bioavailability in the rat.